Benefits of a disease management program for Sickle Cell Disease in Germany 2011-2019: the increased use of hydroxyurea correlates with a reduced frequency of acute chest syndrome - Kunz, Joachim; Schlotmann, Andreas; Daubenbüchel, Andrea; Lobitz, Stephan; Jarisch, Andrea; Grosse, Regine; Cario, Holger; Oevermann, Lena; Hakimeh, Dani; Tagliaferri, Laura; Kulozik, Andreas (Journal of Clinical Medicine, 2021)
Gesehen am 27.01.2022